CDH1 and neoplasm: Analysis of the correlation between E-cadherin expression in 54 OC patient tissues and clinicopathological features and patient survival demonstrated that E-cadherin immunoreactivity was associated with FIGO stage, tumor differentiation and the presence of metastasis; the 5-year survival rate of patients with negative E-cadherin expression was significantly lower than the survival rate of patients with positive-E-cadherin expression.